Cumberland Pharmaceuticals Inc.CPIXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Trend
Above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-162.92%
↑ 41% above average
Average (39q)
-278.05%
Historical baseline
Range
High:223.57%
Low:-8265.72%
CAGR
+0.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -162.92% |
| Q2 2025 | -157.86% |
| Q1 2025 | 170.14% |
| Q4 2024 | -8.71% |
| Q3 2024 | -65.04% |
| Q2 2024 | 45.07% |
| Q1 2024 | 69.75% |
| Q4 2023 | -231.04% |
| Q3 2023 | -8265.72% |
| Q2 2023 | 101.49% |
| Q1 2023 | 32.76% |
| Q4 2022 | -689.29% |
| Q3 2022 | 84.37% |
| Q2 2022 | -42.92% |
| Q1 2022 | 70.33% |
| Q4 2021 | -178.50% |
| Q3 2021 | -8.89% |
| Q2 2021 | -342.72% |
| Q1 2021 | 81.43% |
| Q4 2020 | -44.45% |
| Q3 2020 | 23.55% |
| Q2 2020 | 14.36% |
| Q1 2020 | -85.08% |
| Q4 2019 | 46.00% |
| Q3 2019 | -206.97% |
| Q2 2019 | -240.34% |
| Q1 2019 | 92.19% |
| Q4 2018 | -25.23% |
| Q3 2018 | -107.93% |
| Q2 2018 | 64.56% |
| Q1 2018 | -171.47% |
| Q4 2017 | -7.62% |
| Q3 2017 | 50.06% |
| Q2 2017 | -155.53% |
| Q1 2017 | 31.29% |
| Q4 2016 | -835.69% |
| Q3 2016 | 223.57% |
| Q2 2016 | 78.96% |
| Q1 2016 | -207.71% |
| Q4 2015 | -160.05% |